491 related articles for article (PubMed ID: 22540142)
41. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
[TBL] [Abstract][Full Text] [Related]
43. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
[TBL] [Abstract][Full Text] [Related]
44. [Relevance of the clinical-pathological predictive factors in force in chromophobe renal cell cancer].
Pardo P; RodrÃguez-Faba O; Palou J; Algaba F; Breda A; Esquena S; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):527-31. PubMed ID: 22365081
[TBL] [Abstract][Full Text] [Related]
45. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
46. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.
Paner GP; Amin MB; Alvarado-Cabrero I; Young AN; Stricker HJ; Moch H; Lyles RH
Am J Surg Pathol; 2010 Sep; 34(9):1233-40. PubMed ID: 20679882
[TBL] [Abstract][Full Text] [Related]
47. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
Dall'Oglio MF; Antunes AA; Sarkis AS; Crippa A; Leite KR; Lucon AM; Srougi M
BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
[TBL] [Abstract][Full Text] [Related]
48. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
49. Chromophobe renal cell carcinoma: the impact of tumor grade on outcome.
Cheville JC; Lohse CM; Sukov WR; Thompson RH; Leibovich BC
Am J Surg Pathol; 2012 Jun; 36(6):851-6. PubMed ID: 22367296
[TBL] [Abstract][Full Text] [Related]
50. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
51. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
52. Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.
Takagi T; Kondo T; Izuka J; Kobayashi H; Tomita E; Hashimoto Y; Tanabe K
Int J Urol; 2011 Dec; 18(12):806-12. PubMed ID: 21917022
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
[TBL] [Abstract][Full Text] [Related]
54. Cytohistological study of clear cell carcinoma of kidney with special reference to nuclear grading and tumor size.
Mondal SK
Diagn Cytopathol; 2012 Dec; 40(12):1083-7. PubMed ID: 21563327
[TBL] [Abstract][Full Text] [Related]
55. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
[TBL] [Abstract][Full Text] [Related]
56. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
[TBL] [Abstract][Full Text] [Related]
57. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
58. Predictors of locally advanced and metastatic disease in patients with small renal masses.
Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
60. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]